January Therapeutics, Inc. — Form D
January Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-02. The offering totals $1.5M, of which $375K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-02
- Form: D
- Accession: 0001708145-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $375K
- Remaining: $1.1M
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2017-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287926
Issuer
- Name: January Therapeutics, Inc.
- CIK: 0001708145
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 11575 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO, CA, 92121
- Phone: 858-255-0682
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Samuel Ellis | Director | Dallas, TX |
| David Mizrahi | Director | San Diego, CA |
| Jason Kahana | Director | San Diego, CA |
| Jason Kahana | Executive Officer | San Diego, CA |
| Robin Jackman | Director | San Diego, CA |
| Robin Jackman | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More